betamethasone has been researched along with etretinate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Baba, S; Suzuki, H; Usuba, S | 1 |
| Christiansen, JV; Holm, P; Møller, R; Reymann, F; Schmidt, H | 1 |
| Akiyama, M; Kojima, D; Kono, M; Okuno, Y; Suga, Y; Takeichi, T; Tsukamoto, K | 1 |
1 trial(s) available for betamethasone and etretinate
| Article | Year |
|---|---|
Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Betamethasone; Betamethasone Valerate; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Etretinate; Female; Humans; Male; Middle Aged; Psoriasis; Random Allocation; Tretinoin | 1982 |
5 other study(ies) available for betamethasone and etretinate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Distribution of nuclear DNase in psoriasis vulgaris and its changes after several therapies--a study of immunohistochemistry].
Topics: Administration, Cutaneous; Administration, Oral; Betamethasone; Cell Nucleus; Clobetasol; Deoxyribonucleases; Drug Evaluation; Etretinate; Humans; Immunoenzyme Techniques; Mitosis; Mitotic Index; Psoriasis; PUVA Therapy; Skin | 1988 |
A combination of low-dose systemic etretinate and topical calcipotriol/betamethasone dipropionate treatment for hyperkeratosis and itching in Olmsted syndrome associated with a TRPV3 mutation.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Betamethasone; Calcitriol; Drug Combinations; Drug Therapy, Combination; Etretinate; Humans; Keratolytic Agents; Keratosis; Male; Ointments; Pruritus; Syndrome; Treatment Outcome; TRPV Cation Channels | 2017 |